The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 105K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuhné, M. R.
Right arrow Articles by Calderhead, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuhné, M. R.
Right arrow Articles by Calderhead, D. M.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1997/7/337/ $5.00
The Journal of Experimental Medicine, Volume 186, Number 2, July 21, 1997 337-342

Brief Definitive Reports

Assembly and Regulation of the CD40 Receptor Complex in Human B Cells

Michelle R. Kuhné{ddagger}, Michael Robbins*, John E. Hambor*, Matthew F. Mackey§, Yoko Kosaka§, Toshihide Nishimura{ddagger}, Jason P. Gigley{ddagger}, Randolph J. Noelle{ddagger}, and David M. Calderhead{ddagger}

From the * Department of Molecular Sciences, Pfizer, Incorporated, Groton, Connecticut 06340; the {ddagger} Department of Microbiology and the § Graduate Program in Molecular and Cellular Biology, Dartmouth Medical School, Lebanon, New Hampshire 03756

CD40 is a member of the tumor necrosis factor (TNF) receptor superfamily. Studies with human B cells show that the binding of CD154 (gp39, CD40L) to CD40 recruits TNF receptor– associated factor 2 (TRAF2) and TRAF3 to the receptor complex, induces the downregulation of the nonreceptor-associated TRAFs in the cell and induces an increased expression of Fas on the cell surface. Combined signaling through the interluekin 4 receptor and CD40 induces an increased expression of Fas with a commensurate increase in the level of TRAF2, but not TRAF3, that is recruited to the receptor complex. In contrast, engagement of the membrane immunoglobulin and CD40 limits Fas upregulation and reduces the recruitment of TRAF2, relative to TRAF3, to the CD40 receptor complex. These studies show that the TRAF composition of the CD40 receptor complex can be altered by signals that influence B cell differentiation.

Address correspondence to Randolph J. Noelle at the Department of Microbiology, Dartmouth Medical School, Lebanon, NH 03756. Phone: 603-650-7670; FAX: 603-650-6223; E-mail: rjn{at}dartmouth.edu


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS